CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $15,378,206
- in 4 filings, $15.4M under 10b5-1 plans
Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-24 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale 10b5-1 | −1,768 | $305.38 | $540K | 49,611 |
| 2023-03-17 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale 10b5-1 | −360 | $294.52 | $106K | 53,019 |
| 2023-03-17 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale 10b5-1 | −784 | $295.43 | $232K | 52,235 |
| 2023-03-17 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale 10b5-1 | −240 | $296.30 | $71K | 51,995 |
| 2023-03-17 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale 10b5-1 | −360 | $298.09 | $107K | 51,635 |
| 2023-03-17 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale 10b5-1 | −240 | $299.58 | $72K | 51,395 |
| 2023-03-17 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale 10b5-1 | −16 | $301.13 | $5K | 51,379 |
| 2023-03-16 | Sanna Bastiano EVP, Cell & Genetic Therapies | Sale 10b5-1 | −2,482 | $300.54 | $746K | 49,532 |
| 2023-03-16 | Sanna Bastiano EVP, Cell & Genetic Therapies | Sale 10b5-1 | −264 | $301.07 | $79K | 49,268 |
| 2023-03-13 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale | −24 | $288.31 | $7K | 56,021 |
| 2023-03-13 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale | −420 | $292.41 | $123K | 55,061 |
| 2023-03-13 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale | −1,153 | $293.35 | $338K | 54,448 |
| 2023-03-13 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale | −715 | $294.52 | $211K | 53,733 |
| 2023-03-13 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale | −292 | $295.89 | $86K | 53,441 |
| 2023-03-13 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale | −62 | $296.77 | $18K | 53,379 |
| 2023-03-10 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale | −361 | $286.64 | $103K | 57,772 |
| 2023-03-10 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale | −515 | $287.83 | $148K | 57,257 |
| 2023-03-10 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale | −327 | $288.91 | $94K | 56,930 |
| 2023-03-10 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale | −30 | $289.44 | $9K | 56,900 |
| 2023-03-10 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Sale | −541 | $291.47 | $158K | 56,359 |
Page 32 of 40 · 781 trades